Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.64 |
| ▸ | LMNA | P02545 | 4/20 | 0.60 |
| ▸ | ESR1 | P03372 | 5/20 | 0.58 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | F2 | P00734 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 4/20 | 0.56 |
| ▸ | CA1 | P00915 | 4/20 | 0.56 |
| ▸ | CA2 | P00918 | 4/20 | 0.56 |
| ▸ | CA7 | P43166 | 4/20 | 0.56 |
| ▸ | CA9 | Q16790 | 4/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.56 |
| ▸ | MIF | P14174 | 1/20 | 0.53 |
| ▸ | CA3 | P07451 | 1/20 | 0.52 |
| ▸ | TYR | P14679 | 1/20 | 0.52 |
| ▸ | DRD1 | P21728 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22345808 | 0.98 | CES2 (0.61) | CES2LMNAESR1ESR2KMT2A | |
| Hydroquinone SCHEMBL18144646 | 0.98 | CES2 (0.60) | CES2LMNAESR1ESR2KMT2A | |
| Biphenyl SCHEMBL10761998 | 0.91 | ESR1 (0.59) | CES2LMNAESR1ESR2KMT2A | |
| SCHEMBL5669277 | 0.91 | CA1 (0.65) | CES2LMNAESR1ESR2KMT2A | |
| SCHEMBL8717537 | 0.91 | LMNA (0.67) | CES2LMNAKMT2AMAPTF2 | |
| Hydrogen Peroxide SCHEMBL27952375 | 0.88 | LMNA (0.70) | CES2LMNAKMT2AMAPTF2 | |
| Benzene SCHEMBL27793442 | 0.88 | LMNA (0.70) | CES2LMNAKMT2AMAPTF2 | |
| SCHEMBL52413 | 0.88 | LMNA (0.70) | CES2LMNAKMT2AMAPTF2 | |
| SCHEMBL7617231 | 0.86 | LMNA (0.77) | CES2LMNAESR1ESR2KMT2A | |
| SCHEMBL2591454 | 0.85 | LMNA (0.67) | CES2LMNAKMT2AMAPTF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 223 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115297858-B | Pharmaceutical composition for treating hypertrophic cardiomyopathy and treatment method using the same | 赛特瑞恩股份有限公司 | 2024-08-13 | — | — | CN | claimed |
| CN-115297858-A | Pharmaceutical composition for treating hypertrophic cardiomyopathy and treatment method using same | 赛特瑞恩股份有限公司 | 2022-11-04 | — | — | CN | claimed |
| CN-107522669-B | 1 antagonist of transient receptor potential vanillic acid hypotype and its preparation method and application | 重庆美莱德生物医药有限公司 | 2019-12-03 | — | — | CN | claimed |
| CN-107522668-B | TRPV1 antagonist and its preparation method and application | 重庆医科大学 | 2019-12-03 | — | — | CN | claimed |
| WO-2018095353-A1 | SALTS OF AMINOQUINAZOLINE DERIVATIVE AND USES THEREOF | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2018-05-31 | — | — | WO | claimed |
| US-7304182-B2 | Crystalline parahydroxybenzoic acid anhydride and process for preparing the same | KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) | 2007-12-04 | — | — | US | claimed |
| US-20060264670-A1 | Crystal of p-hydroxybenzoic anhydride and process for producing the same | UENO FINE CHEMICALS INDUSTRY, LTD. (JP) | 2006-11-23 | — | — | US | claimed |
| EP-1614673-A1 | CRYSTAL OF p-HYDROXYBENZOIC ANHYDRIDE AND PROCESS FOR PRODUCING THE SAME | KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) | 2006-01-11 | — | — | EP | claimed |
| US-4380587-A | Film badge for determining carbonyl compounds | ARTHUR D. LITTLE, INC. (US) | 1983-04-19 | — | — | US | claimed |
| US-12421204-B2 | Process for preparing chroman compounds | LUPIN LIMITED (IN) | 2025-09-23 | — | — | US | disclosed |
| CN-111065623-B9 | Linker for antibody drug conjugates | 德克萨斯州大学系统董事会 | 2024-10-25 | — | — | CN | disclosed |
| CN-114286818-B | Heterocyclic compounds as BET inhibitors | 诺维逊生物股份有限公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-118652192-A | Linker for antibody drug conjugates | 德克萨斯州大学系统董事会 | 2024-09-17 | — | — | CN | disclosed |
| CN-111065623-B | Linker for antibody drug conjugates | 德克萨斯州大学系统董事会 | 2024-09-03 | — | — | CN | disclosed |
| EP-0155593-B1 | FLUORAN COMPOUNDS AND RECORDING SHEETS CONTAINING THEM | KANZAKI PAPER MANUFACTURING CO., LTD (JP) | 1988-09-07 | — | — | EP | disclosed |
| US-4629800-A | PRESSURE, HEAT AND ELECTROTHERMAL SENSITIVE RECORDING SHEETS; COLOR BLACK | KANZAKI PAPER MANUFACTURING CO., LTD. (JP) | 1986-12-16 | — | — | US | disclosed |
| EP-0155593-A2 | Fluoran compounds and recording sheets containing them | KANZAKI PAPER MANUFACTURING CO., LTD (JP) | 1985-09-25 | — | — | EP | disclosed |
| US-4232026-A | Diazaditwistanes, and pharmaceutical compositions for treating pain in warm blooded animals containing them | MERCK & CO., INC. (US) | 1980-11-04 | — | — | US | disclosed |
| US-3985720-A | Polymerization of ethylenically unsaturated monomer employing a catalyst system comprising dialkylpyrocarbonate, organic acid anhydride, alkaline reagent and H2 O2 | PPG INDUSTRIES, INC. (US) | 1976-10-12 | — | — | US | disclosed |
| US-3978032-A | ALKALINE BUFFER, ANHYDRIDE, PERACID, ALKYL HALOFORMATE | PPG INDUSTRIES, INC. (US) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12421204-B2 | Process for preparing chroman compounds | CASR, P2RY4, ITPR1 | CES2 2776/4885LMNA 3624/4885ESR1 1539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.